Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.12
-0.02 (-0.39%)
At close: Aug 15, 2025, 1:41 PM
Evoke Pharma Fail-to-Deliver
Total FTD Shares
71.92K
Below Average
FTD / Avg. Volume
3.03%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Evoke Pharma Inc. has
71,922
shares failed to deliver, representing 3.03%
of the average daily volume of
2,373,562
shares. Over the past year, the monthly average FTD is
9,798
shares, with the current level 634% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 5.74 | 71.92K | +40764.77% |
| Jun 30, 2025 | 2.6 | 176 | +175.00% |
| May 28, 2025 | 3.52 | 64 | -74.80% |
| Apr 25, 2025 | 2.58 | 254 | +111.67% |
| Mar 21, 2025 | 2.82 | 120 | -49.79% |
| Feb 19, 2025 | 5.3 | 239 | -91.82% |
| Jan 31, 2025 | 4.97 | 2.92K | +818.24% |
| Dec 31, 2024 | 4.42 | 318 | -78.50% |
| Nov 14, 2024 | 4.37 | 1.48K | -37.12% |
| Oct 31, 2024 | 5.85 | 2.35K | +2542.70% |
| Sep 26, 2024 | 5.08 | 89 | -70.13% |
| Aug 30, 2024 | 4.29 | 298 | -71.01% |
| Jul 31, 2024 | 4.8 | 1.03K | -11.00% |
| Jun 24, 2024 | 6.73 | 1.16K | -1.37% |
| May 31, 2024 | 5.7 | 1.17K | +228.93% |
| Apr 30, 2024 | 5.4 | 356 | -84.90% |
| Mar 12, 2024 | 7.8 | 2.36K | +408.19% |
| Feb 29, 2024 | 7.94 | 464 | -86.94% |
| Jan 30, 2024 | 8.05 | 3.55K | +1220.82% |
| Dec 27, 2023 | 12.6 | 269 | +75.82% |
| Nov 30, 2023 | 15.57 | 153 | +50.00% |
| Oct 23, 2023 | 14.4 | 102 | -88.79% |
| Sep 28, 2023 | 12.96 | 910 | -30.48% |
| Aug 08, 2023 | 16.92 | 1.31K | +74.30% |
| Jul 14, 2023 | 20.4 | 751 | -76.45% |
| Jun 29, 2023 | 19.44 | 3.19K | +420.23% |
| May 30, 2023 | 21 | 613 | -79.49% |
| Apr 28, 2023 | 22.51 | 2.99K | +21250.00% |
| Mar 23, 2023 | 31.44 | 14 | -98.34% |
| Feb 23, 2023 | 37.68 | 841 | -89.85% |
| Jan 31, 2023 | 48.48 | 8.28K | n/a |